"Salvage" surgery for primary mediastinal malignancies: is it worthwhile?

Area of Science:

• Thoracic Surgery
• Surgical Oncology
• Mediastinal Tumors

Background:

• Indications and outcomes for salvage surgery in mediastinal tumors remain unclear.
• This study evaluates a single-center experience to determine mortality, morbidity, and long-term results of mediastinal salvage surgery (MSS).

Purpose of the Study:

• To assess the safety and efficacy of mediastinal salvage surgery (MSS) for persistent or recurrent mediastinal tumors.
• To analyze survival rates and complications associated with MSS.

Main Methods:

• Retrospective analysis of 21 patients undergoing MSS between 1998 and 2005.
• Definition of MSS: resection of tumors after prior local treatments or chemotherapy.
• Calculation of overall and disease-specific long-term survival using Kaplan-Meier analysis.

Main Results:

• Twenty-one patients (mean age 41) underwent MSS, including thymic and non-thymic tumors.
• MSS involved complex procedures like vascular resection and cardiopulmonary bypass in some cases.
• Overall mortality was 4.7% and morbidity 19.0%, with 1-, 3-, and 5-year survival rates of 89.7%, 71.2%, and 56.6% respectively.
• Thymic neoplasms demonstrated significantly better long-term survival than non-thymic tumors (p = 0.0128).

Conclusions:

• Mediastinal salvage surgery (MSS) is a viable option for selected patients with persistent or recurrent mediastinal tumors.
• MSS offers a chance for curative treatment with acceptable morbidity and mortality rates.
• Thymic tumors treated with MSS achieve the best long-term survival outcomes.